{"pmid":32466994,"pmcid":"PMC7192111","title":"Potential risks of SARS-CoV-2 infection on reproductive health.","text":["Potential risks of SARS-CoV-2 infection on reproductive health.","The outbreak of 2019 novel coronavirus disease (COVID-19) has become a major pandemic threat worldwide. Such a public health emergency can greatly impact various aspects of people's health and lives. This paper focuses on its potential risks for reproductive health, including the reproductive system and its functioning, as well as gamete and embryo development, which could be affected by the virus itself, drug treatments, chemical disinfectants and psychological effects related to panic during the COVID-19 outbreak.","Reprod Biomed Online","Li, Rong","Yin, Tailang","Fang, Fang","Li, Qin","Chen, Jiao","Wang, Yixin","Hao, Yongxiu","Wu, Gengxiang","Duan, Peng","Wang, Yuanyuan","Cheng, Dan","Zhou, Qi","Zafar, Mohammad Ishraq","Xiong, Chengliang","Li, Honggang","Yang, Jing","Qiao, Jie","32466994"],"abstract":["The outbreak of 2019 novel coronavirus disease (COVID-19) has become a major pandemic threat worldwide. Such a public health emergency can greatly impact various aspects of people's health and lives. This paper focuses on its potential risks for reproductive health, including the reproductive system and its functioning, as well as gamete and embryo development, which could be affected by the virus itself, drug treatments, chemical disinfectants and psychological effects related to panic during the COVID-19 outbreak."],"journal":"Reprod Biomed Online","authors":["Li, Rong","Yin, Tailang","Fang, Fang","Li, Qin","Chen, Jiao","Wang, Yixin","Hao, Yongxiu","Wu, Gengxiang","Duan, Peng","Wang, Yuanyuan","Cheng, Dan","Zhou, Qi","Zafar, Mohammad Ishraq","Xiong, Chengliang","Li, Honggang","Yang, Jing","Qiao, Jie"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32466994","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.rbmo.2020.04.018","keywords":["covid-19","infectious disease","reproductive health"],"topics":["Mechanism","Treatment","Prevention"],"weight":1,"_version_":1668420887119921152,"score":9.490897,"similar":[{"pmid":32466995,"title":"COVID-19 and fertility: a virtual reality.","text":["COVID-19 and fertility: a virtual reality.","The COVID-19 pandemic is an extraordinary global situation, and all countries have adopted their own strategies to diminish and eliminate the spread of the virus. All measures are in line with the recommendations provided by the World Health Organization. Scientific societies, such as the European Society for Human Reproduction and Embryology and American Society for Reproductive Medicine, have provided recommendations and guidance to overcome and flatten the growing curve of infection in patients who undergo IVF treatments. Although there is as yet no evidence that the virus causing COVID-19 might have negative effects on IVF outcomes, fertility treatments have been postponed in order to support healthcare systems by avoiding placing them under additional stress. The possibility of the virus affecting sperm function and egg performance cannot be excluded. In addition, an indirect effect of the virus on gametes and embryos during their manipulation cannot be ruled out. This commentary aims to provide some ideas on the possible effect of the virus on gametes and embryos, as well as how it could affect the normal functioning of the embryology laboratory.","Reprod Biomed Online","Anifandis, George","Messini, Christina I","Daponte, Alexandros","Messinis, Ioannis E","32466995"],"abstract":["The COVID-19 pandemic is an extraordinary global situation, and all countries have adopted their own strategies to diminish and eliminate the spread of the virus. All measures are in line with the recommendations provided by the World Health Organization. Scientific societies, such as the European Society for Human Reproduction and Embryology and American Society for Reproductive Medicine, have provided recommendations and guidance to overcome and flatten the growing curve of infection in patients who undergo IVF treatments. Although there is as yet no evidence that the virus causing COVID-19 might have negative effects on IVF outcomes, fertility treatments have been postponed in order to support healthcare systems by avoiding placing them under additional stress. The possibility of the virus affecting sperm function and egg performance cannot be excluded. In addition, an indirect effect of the virus on gametes and embryos during their manipulation cannot be ruled out. This commentary aims to provide some ideas on the possible effect of the virus on gametes and embryos, as well as how it could affect the normal functioning of the embryology laboratory."],"journal":"Reprod Biomed Online","authors":["Anifandis, George","Messini, Christina I","Daponte, Alexandros","Messinis, Ioannis E"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32466995","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.rbmo.2020.05.001","keywords":["covid-19","clinical embryology","fertility"],"topics":["Prevention"],"weight":1,"_version_":1668167109989892096,"score":177.60858},{"pmid":32365180,"title":"Potential influence of COVID-19/ACE2 on the female reproductive system.","text":["Potential influence of COVID-19/ACE2 on the female reproductive system.","The 2019 novel coronavirus (2019-nCoV) appeared in December 2019 and then spread throughout the world rapidly. The virus invades the target cell by binding to angiotensin-converting enzyme (ACE) 2 and modulates the expression of ACE2 in host cells. ACE2, a pivotal component of the renin-angiotensin system, exerts its physiological functions by modulating the levels of angiotensin II (Ang II) and Ang-(1-7). We reviewed the literature that reported the distribution and function of ACE2 in the female reproductive system, hoping to clarify the potential harm of 2019-nCoV to female fertility. The available evidence suggests that ACE2 is widely expressed in the ovary, uterus, vagina and placenta. Therefore, we believe that apart from droplets and contact transmission, the possibility of mother-to-child and sexual transmission also exists. Ang II, ACE2 and Ang-(1-7) regulate follicle development and ovulation, modulate luteal angiogenesis and degeneration, and also influence the regular changes in endometrial tissue and embryo development. Taking these functions into account, 2019-nCoV may disturb the female reproductive functions through regulating ACE2.","Mol Hum Reprod","Jing, Yan","Run-Qian, Li","Hao-Ran, Wang","Hao-Ran, Chen","Ya-Bin, Liu","Yang, Gao","Fei, Chen","32365180"],"abstract":["The 2019 novel coronavirus (2019-nCoV) appeared in December 2019 and then spread throughout the world rapidly. The virus invades the target cell by binding to angiotensin-converting enzyme (ACE) 2 and modulates the expression of ACE2 in host cells. ACE2, a pivotal component of the renin-angiotensin system, exerts its physiological functions by modulating the levels of angiotensin II (Ang II) and Ang-(1-7). We reviewed the literature that reported the distribution and function of ACE2 in the female reproductive system, hoping to clarify the potential harm of 2019-nCoV to female fertility. The available evidence suggests that ACE2 is widely expressed in the ovary, uterus, vagina and placenta. Therefore, we believe that apart from droplets and contact transmission, the possibility of mother-to-child and sexual transmission also exists. Ang II, ACE2 and Ang-(1-7) regulate follicle development and ovulation, modulate luteal angiogenesis and degeneration, and also influence the regular changes in endometrial tissue and embryo development. Taking these functions into account, 2019-nCoV may disturb the female reproductive functions through regulating ACE2."],"journal":"Mol Hum Reprod","authors":["Jing, Yan","Run-Qian, Li","Hao-Ran, Wang","Hao-Ran, Chen","Ya-Bin, Liu","Yang, Gao","Fei, Chen"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32365180","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1093/molehr/gaaa030","keywords":["2019-ncov","ang-(1-7)","covid-19","angiotensin ii","angiotensin-converting enzyme 2","breastfeeding","coronavirus","female reproductive system","pregnancy"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1666138496008454147,"score":149.75569},{"pmid":32301600,"pmcid":"PMC7169922","title":"A review of initial data on pregnancy during the COVID-19 outbreak: implications for assisted reproductive treatments.","text":["A review of initial data on pregnancy during the COVID-19 outbreak: implications for assisted reproductive treatments.","The current outbreak of the novel 2019 coronavirus disease (COVID-19) started in China in December 2019 and has since spread to several other countries. On March 25, 2020, a total of 375,498 cases had been confirmed globally with 2,201 cases in Brazil, showing the urgency of reacting to this international public health emergency. While in most cases, mild symptoms are observed, in some cases the infection leads to serious pulmonary disease. As a result, the possible consequences of the COVID-19 outbreak for pregnant women and its potential effects on the management of assisted reproductive treatments, demand attention. In this review, we summarize the latest research progress related to COVID-19 epidemiology and the reported data of pregnant women, and discuss the current evidence of COVID-19 infections during pregnancy and its potential consequences for assisted reproductive treatments. Reported data suggest that symptoms in pregnant women are similar to those in other people, and that there is no evidence for higher maternal or fetal risks. However, considering the initial data and lack of comprehensive knowledge on the pathogenesis of SARS-CoV-2 during pregnancy, human reproduction societies have recommended postponing the embryo transfers and do not initiate new treatment cycles. New evidence must be considered carefully in order to adjust these recommendations accordingly at any time and to guide assisted reproductive treatments.","JBRA Assist Reprod","Monteleone, Pedro Aa","Nakano, Mayra","Lazar, Victor","Gomes, Alecsandra P","de, Hamilton Martin","Bonetti, Tatiana Cs","32301600"],"abstract":["The current outbreak of the novel 2019 coronavirus disease (COVID-19) started in China in December 2019 and has since spread to several other countries. On March 25, 2020, a total of 375,498 cases had been confirmed globally with 2,201 cases in Brazil, showing the urgency of reacting to this international public health emergency. While in most cases, mild symptoms are observed, in some cases the infection leads to serious pulmonary disease. As a result, the possible consequences of the COVID-19 outbreak for pregnant women and its potential effects on the management of assisted reproductive treatments, demand attention. In this review, we summarize the latest research progress related to COVID-19 epidemiology and the reported data of pregnant women, and discuss the current evidence of COVID-19 infections during pregnancy and its potential consequences for assisted reproductive treatments. Reported data suggest that symptoms in pregnant women are similar to those in other people, and that there is no evidence for higher maternal or fetal risks. However, considering the initial data and lack of comprehensive knowledge on the pathogenesis of SARS-CoV-2 during pregnancy, human reproduction societies have recommended postponing the embryo transfers and do not initiate new treatment cycles. New evidence must be considered carefully in order to adjust these recommendations accordingly at any time and to guide assisted reproductive treatments."],"journal":"JBRA Assist Reprod","authors":["Monteleone, Pedro Aa","Nakano, Mayra","Lazar, Victor","Gomes, Alecsandra P","de, Hamilton Martin","Bonetti, Tatiana Cs"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301600","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.5935/1518-0557.20200030","keywords":["covid-19","sars-cov-2","assisted reproduction","pregnancy"],"locations":["China","Brazil"],"countries":["Brazil","China"],"countries_codes":["BRA|Brazil","CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1666138494787911680,"score":144.93433},{"pmid":32436744,"title":"Impact of COVID-19 on reproductive health and maternity services in low resource countries.","text":["Impact of COVID-19 on reproductive health and maternity services in low resource countries.","Purpose: Coronavirus Disease-2019 (COVID-19) is a rapidly evolving pandemic. It is well-known that pregnant women are more susceptible to viral infection due to immune and anatomic factors. Therefore, the viral pandemic might affect the reproductive health and maternity services especially in low-resource countries.Materials and methods: In this article, we tried to highlight the impact of COVID-19 on reproductive health and maternity health services in low resource countries with emphasis on adapting some of the published best practice recommendations to suit a struggling environment.Conclusion: Pregnant women residing in low resource countries represent a uniquely vulnerable group in epidemics due to several factors. Maternity services in low resource countries are adapting to provide antenatal and postnatal care amidst a rapidly shifting health system environment due to the COVID-19 pandemic.","Eur J Contracept Reprod Health Care","Abdelbadee, Ahmed Y","Abbas, Ahmed M","32436744"],"abstract":["Purpose: Coronavirus Disease-2019 (COVID-19) is a rapidly evolving pandemic. It is well-known that pregnant women are more susceptible to viral infection due to immune and anatomic factors. Therefore, the viral pandemic might affect the reproductive health and maternity services especially in low-resource countries.Materials and methods: In this article, we tried to highlight the impact of COVID-19 on reproductive health and maternity health services in low resource countries with emphasis on adapting some of the published best practice recommendations to suit a struggling environment.Conclusion: Pregnant women residing in low resource countries represent a uniquely vulnerable group in epidemics due to several factors. Maternity services in low resource countries are adapting to provide antenatal and postnatal care amidst a rapidly shifting health system environment due to the COVID-19 pandemic."],"journal":"Eur J Contracept Reprod Health Care","authors":["Abdelbadee, Ahmed Y","Abbas, Ahmed M"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32436744","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1080/13625187.2020.1768527","keywords":["covid-19","reproductive health","low-resource countries","maternity services"],"topics":["Prevention"],"weight":1,"_version_":1667521393656332289,"score":140.88826},{"pmid":32354664,"pmcid":"PMC7141638","title":"After corona: there is life after the pandemic.","text":["After corona: there is life after the pandemic.","The current pandemic of Coronavirus Disease 2019 (COVID-19) has focused the attention of medical-care providers away from non-life-threatening diseases, including infertility. Although infertility does not jeopardize the physical survival of infertile couples, it does jeopardize their future quality of life. Human infertility can be caused by a number of factors, some of which are age-dependent, and their effects may become irreversible if appropriate measures are not taken in time to prevent irreversible childlessness. Accordingly, each case of infertility should be evaluated comprehensively to establish its position of priority. Assisted reproductive technology (ART) makes it possible to separate fertilization and pregnancy in time. Whereas pregnant women infected with coronavirus may have an increased risk of adverse neonatal outcomes, gametes do not transmit COVID-19. Thus, performing ovarian stimulation and fertilization without delay, freezing the resulting embryos and delaying embryo transfer until the end of the pandemic appears to be the best strategy at present.","Reprod Biomed Online","Tesarik, Jan","32354664"],"abstract":["The current pandemic of Coronavirus Disease 2019 (COVID-19) has focused the attention of medical-care providers away from non-life-threatening diseases, including infertility. Although infertility does not jeopardize the physical survival of infertile couples, it does jeopardize their future quality of life. Human infertility can be caused by a number of factors, some of which are age-dependent, and their effects may become irreversible if appropriate measures are not taken in time to prevent irreversible childlessness. Accordingly, each case of infertility should be evaluated comprehensively to establish its position of priority. Assisted reproductive technology (ART) makes it possible to separate fertilization and pregnancy in time. Whereas pregnant women infected with coronavirus may have an increased risk of adverse neonatal outcomes, gametes do not transmit COVID-19. Thus, performing ovarian stimulation and fertilization without delay, freezing the resulting embryos and delaying embryo transfer until the end of the pandemic appears to be the best strategy at present."],"journal":"Reprod Biomed Online","authors":["Tesarik, Jan"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32354664","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.rbmo.2020.04.002","keywords":["assisted reproduction safety","assisted reproduction urgency","covid-19","coronavirus","deferred pregnancy"],"topics":["Prevention"],"weight":1,"_version_":1666138495242993664,"score":140.83644}]}